VOGX

Vogenx Inc

13.46

Aug 13 • 4:00 AM ET +0.46 (3.53%)

Healthcare Biotechnology USA Micro NASD

Index	-
Market Cap	187.21M
Enterprise Value	187.80M
Income	-
Sales	-
Book/sh	-0.10
Cash/sh	0.02
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Aug 12, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	748.83
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.11
Current Ratio	0.11
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / No

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	-
Insider Trans	-
Inst Own	-
Inst Trans	-
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	1.73%
SMA50	1.73%
SMA200	1.73%
Trades

Shs Outstand	13.91M
Shs Float	-
Short Float	-
Short Ratio	-
Short Interest	-
52W High	13.88 -3.04%
52W Low	12.95 3.93%
Volatility	- -
ATR (14)	0.69
RSI (14)	-
Beta	-
Rel Volume	0.00
Avg Volume	683.98K
Volume	60

Perf Week	-
Perf Month	-
Perf Quarter	-
Perf Half Y	-
Perf YTD	3.53%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	13.00
Price	13.46
Change %	3.53%

Vogenx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery and development of treatments for serious metabolic and gastrointestinal diseases. The company was founded by James Green, William Wilkison, and Steven Delmar on February 5, 2021 and is headquartered in Raleigh, NC.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VOGX

Vogenx Inc

Upgrade your Finviz experience